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Abstract: Capsaicin-sensitive peptidergic sensory nerves play complex, mainly protective regulatory
roles in the inflammatory cascade of the joints via neuropeptide mediators, but the mechanisms of
the hyperacute arthritis phase has not been investigated. Therefore, we studied the involvement
of these afferents in the early, “black box” period of a rheumatoid arthritis (RA) mouse model.
Capsaicin-sensitive fibres were defunctionalized by pretreatment with the ultrapotent capsaicin
analog resiniferatoxin and arthritis was induced by K/BxN arthritogenic serum. Disease severity
was assessed by clinical scoring, reactive oxygen species (ROS) burst by chemiluminescent, vascular
permeability by fluorescent in vivo imaging. Contrast-enhanced magnetic resonance imaging was
used to correlate the functional and morphological changes. After sensory desensitization, both early
phase ROS-burst and vascular leakage were significantly enhanced, which was later followed by
the increased clinical severity scores. Furthermore, the early vascular leakage and ROS-burst were
found to be good predictors of later arthritis severity. We conclude that the anti-inflammatory role of
peptidergic afferents depends on their activity in the hyperacute phase, characterized by decreased
cellular and vascular inflammatory components presumably via anti-inflammatory neuropeptide
release. Therefore, these fibres might serve as important gatekeepers in RA.
Keywords: sensory neuropeptides; inflammation; neurogenic inflammation; arthritis; novel drug tar-
gets
1. Introduction
Rheumatoid arthritis (RA) is globally the most common autoimmune joint disease,
thus it represents a considerable burden for both the patients and the society. The last
decades have seen tremendous improvement in the management of RA due to major
advances in its biological therapy (e.g., monoclonal antibodies) [1]. Nonetheless, chronic
sequelae of RA such as joint pain remain to be challenging to manage. Hence, it is im-
portant to better understand the pathophysiological underpinnings of the neurogenic
factors involved in the inflammatory cascade, in order to identify the novel pathways for
therapeutic interventions.
Capsaicin-sensitive afferents are abundant on the periphery, they densely innervate
the joint capsule and synovial tissue. These sensory nerves are not only important for pain
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perception, but also exert efferent functions via the local release of a plethora of mainly
peptide mediators [2–4]. Some of these sensory neuropeptides are primarily algogenic and
proinflammatory, while others are anti-inflammatory and analgesic. Thus, the net effect
is variable and dependent on the proportion of different mediators and their roles in the
complexity of the pathophysiological cascade. A characteristic feature of capsaicin-sensitive
afferents is the expression of transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1
(TRPA1) receptors. These receptors can be activated by a variety of endo-, and exogenous
substances including capsaicin, resiniferatoxin (RTX), protons (in case of tissue acidosis),
and a diverse array of proinflammatory mediators [5,6]. Receptor activation leads to the
release of proinflammatory neuropeptides such as the tachykinin family, calcitonin gene-
related peptide (CGRP), vasoactive intestinal polypeptide (VIP), and pituitary adenylate
cyclase-activating polypeptide (PACAP). These mediators induce vasodilation, plasma
protein extravasation, and early inflammatory cell activation, collectively called neurogenic
inflammation [7]. However, anti-inflammatory mediators, such as somatostatin or galanin
can also be released [8]. It has been shown using gene-deficient mice that selective deletion
of the genes of such peptides can alter disease severity in mouse models of RA [9,10].
The first sporadic clinical data about neurogenic factors playing a significant role in
the development of autoimmune joint disorders were published nearly a century ago. Since
then it has become established that neurogenic pathways play a pivotal role not only in
inflammation, but also in the normal homeostatic function of the joints [11,12]. It has been
confirmed, that there is a bidirectional communication between peripheral nociceptors and
immune cells via their released mediators [13,14]. Clinical evidence gathered in the recent
decades also indicates that altered levels of these neuropeptides in RA patients have a
profound influence on disease severity [15–19], but our understanding of the mechanisms
responsible for this effect is still incomplete.
Therefore, in the present experiment we used the K/BxN serum transfer mechanism
model of RA and investigated the role of capsaicin-sensitive sensory nerves in vascular
and cellular components of this condition. This model is induced by transferring the
autoantibody-rich serum of the transgenic K/BxN mice into naïve recipients, where it
elicits a robust polyarthritis. The inflammation is mainly caused by the autoantibodies
against the ubiquitously expressed glucose-6-phosphate isomerase (G6PI) self-antigen,
which elicits a robust activation of the innate immune system [20]. As the K/BxN serum
transfer model relies on passive transfer of autoantibody-rich serum into recipient mice,
it triggers autoimmune joint inflammation with nearly 100% penetration in a variety of
susceptible mouse strains. We previously showed that selective desensitization of these
nerve terminals leads to increased disease severity in multiple models of RA [9,21–24]. In
the K/BxN serum transfer model increased disease severity measured by hind limb volume
and clinical severity scoring was found, coupled with diminished mechanical hyperalgesia
in desensitized mice. Prior results thus indicate, that while capsaicin-sensitive afferents
are crucial to inflammatory hyperalgesia, they also possess important anti-inflammatory
properties on the periphery. However in the earlier studies the primary focus was on
the acute to chronic phases of the disease, while it has been shown that in the K/BxN
model subtle, primarily microvascular changes (vasodilation and increased permeability
facilitating edema formation and leukocyte transmigration) occur within minutes to hours,
and predate any functional or morphological changes, which typically take at least a day to
develop [25]. As neurogenic inflammation is heavily dependent on microvascular response,
in this study we aimed to shift the focus toward this very early “hyperacute” phase of the
model, where functional or morphological changes are nonexistent. Recent developments
in the field of in vivo optical imaging have also shown that the extremely weak photonic
radiation caused by the decay of free radicals such as singlet oxygen can be imaged without
utilizing exogenously administered imaging probes in inflammatory arthritis, albeit their
detection remains challenging [26,27]. Thus, in this study we also aimed to determine
whether with a dedicated imaging sequence having increased sensitivity this phenomenon
is within the grasp of commercially available imaging systems.
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Altogether, in this study we therefore aimed to assess the role of capsaicin-sensitive
afferents in a mouse model of the K/BxN serum transfer arthritis, using in vivo optical
imaging to measure the inflammatory vascular leakage and reactive oxygen species (ROS)
burst due to leukocyte activation in the hyperacute phase of the disease. Functional
inflammatory changes such as edema and erythema were assessed by semiquantitative
clinical scoring. For better evaluation of the morphological parameters in vivo contrast
enhanced magnetic resonance imaging (MRI) of the inflamed joints was also performed.
The experimental layout has been summarized in Figure 1.
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2. Results
2.1. Increased Arthritis Severity after Sensory Defunctionalization
Significant tibiotarsal joint edema and hindpaw hyperemia developed on day 1 in
both the non-desensi ized and RTX-desensitized K/BxN serum-treated arthritic groups. It
remain d significantly gre ter in RTX-pretreat mice compared to heir non-desensitized
controls from day 2 onwards till the end of the experiment, dis ase sev rity peaking by
day 5 (Figure 2).
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Figure 2. Clinical arthritis severity scores of non-desensitized and RTX-desensitized (sensory de-
functionalized) mice. Data points represent mean values ± SEM of n = 6/group, both hindlimbs;
two-way ANOVA and Fishers LSD test, * p < 0.05, *** p < 0.001 vs. pre-treatment self-control values,
## p < 0.01, ### p < 0.001 vs. non-pretreated group.
2.2. Facilitated Early Arthritic Vascular Hyperpermeability after Sensory Defunctionalization
Fluorescent tracer accumulation reflecting vascular permeability and plasma leakage
was significantly increased in RTX-desensitized mice, but not in the non-desensitized
arthritic group as early as 5 h after K/BxN serum transfer. On day 2 contrast agent
Int. J. Mol. Sci. 2021, 22, 1682 4 of 13
extravasation was robustly increased in both groups compared to the pretreatment baseline
value, while still being significantly greater in the desensitized animals (Figure 3A,B).
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2.3. Increased Early-Phase Arthritic Free Radical Production after Sensory Defunctionalization
Already at 3 h following K/BxN serum challenge both RTX-desensitized and non-
desensitized arthritic groups demonstrated significantly increased luminescence signal
indicating elevated free radical production. Both at 3 h and day 1 the luminescence
signal was significantly greater in the hindlimbs of RTX-pretreated mice. Later the signal
became more circumscribed to the ankle joints and also subsided in both groups by day
4 (Figure 4A,B).
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 Figure 4. Inflammatory reactive oxygen species production of leukocytes assessed by in vivo luminescence imaging and
the free radical sensor L-012. (A) Representative images and (B) Luminescence signal of the ankle joints. Individual values,
means, ± SEM, two-way ANOVA and Fishers LSD test, n = 6/group, both limbs. * p < 0.05, ** p < 0.01, *** p < 0.001 vs.
self-control values before arthritis induction, # p < 0.05 vs. non-pretreated arthritic group.
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Spontaneous luminescence signals were similar in both groups prior to the induction
of inflammatory arthritis. 3 h after the transfer of the autoantibody-rich serum, a modest
but significant increase was observed in the RTX-pretreated mice compared to both their
own pre-challenge values and the non-pretreated ones (Figure 5A,B). Despite the increasing
clinical severity this photon emission returned to pre-challenge levels in RTX-pretreated
mice, and in the non-pretreated group it became even lower than the initial self-control
values. To assess how well spontaneous photon emission and L-012 derived luminescence
signal correlates the paired values of these measurements were plotted against each other,
showing a weak but significant correlation between these parameters (Figure 5C).
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Figure 5. In vivo spontaneous ROS-derived photon emission. (A) Representative luminescence
images, (B) Quantitative data. Individual values, means, ± SEM, two-way ANOVA and Fishers LSD
test, n = 6/group, both hindlimbs. * p < 0.05, vs. self-control values before arthritis induction, # p < 0.05
vs. non-pretreated arthritic group. (C) Linear regression and correlation of the spontaneous photon
signal and the L-012-derived luminescence. All matched data pairs shown from both non-pretreated
a d RTX-pr treated groups. * p < 0.05.
2.4. Early Vascular Hyperpermeability and ROS Production Are Good Predictors of Later Disease
Severity, and Correlate well with Free Radical Production
We also compared the semiquantitative clinical arthritis severity scores on day 1 with
both the luminescent ROS production signal at 3 h and the vascular leakage fluorescent
signal at 5 h both in the RTX-desensitized and non-desensitized groups. A significant
Int. J. Mol. Sci. 2021, 22, 1682 6 of 13
trend was observed indicating that the early-phase plasma leakage correlates well with
the macroscopic changes reflected by the clinical severity score, which emerges only later
(Figure 6A,B). Comparison of the early plasma leakage and free radical production also
showed a positive correlation (Figure 6C).
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Figure 6. Linear regression and correlation of (A) L-012 luminescence signal at 3 h and the clinical
severity score on day 1. (B) Fluorescent vascular signal at 5 h and the day 1 score, (C) the vascular
fluorescent signal and the L-012-derived luminescence. All matched data pairs shown from both
non- retreate an - retreate gro s. * p 0.05, ** p 0.01.
2.5. Synovial Enhancement in the Contrast-Enhanced Ankle Joint MRI
The soft tissue edema was well demonstrated by the MRI in line with macroscopic ob-
servations. On the postcontrast acquisition the greatest enhancement was observed in and
around the ankle and smaller tarsal joints, suggesting synovial and intra-articular accumu-
lation of the contrast agent (Figure 7A). The semiquantitative evaluation showed increasing
tendency of the joint signal in RTX-pretreated mice. However, due to the low throughput
of the technique, and the small number of imaged subjects, no statistically significant dif-
ference could be determined between the RTX-desensitized and non-desensitized groups
(Figure 7B).
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3. Discussion
This study demonstrates that the protective, anti-inflammatory effect of capsaicin-
sensitive afferents predominantly manifests in the early, hyperacute phase of the K/BxN
serum transfer model of RA. This is largely due to diminished vasodilation and vascular
dysregulatio following the autoantibody-challenge, as well as in reduced early ROS-burst
an leukocyte activation. This results in a decreased clinical severity later. Th MRI imag-
ing showe that persistent inflammatory hyperenhancement the mature phase of the
model is predominantly localized to the syn vial tissu s. These fi d gs suppo t earlier
results demon trating increased vascular permeability in the same model after sensory d -
functionalization, which affects th sites that later develop clinically appar nt arthritis [28].
The s novial tissue is particularly highly vascularized, and also densely innervated by
bo myelinated and unmyelinated nerve fibers [29]. This is also supported by the results
of the MRI imaging in our experiment, showing incr ased synovial enhancement post iv.
contrast agent. T se findin s altogether suggest that early sy ovi l vascular leakiness
and consequent leukocyte extravasation are contr ll d by locally releas d mediators from
the capsaicin-sensitive peptidergic afferents.
We previously showed in the K/BxN serum transfer, proteoglycan-induced autoim-
mune arthritis, and complete Freund’s adjuvant-induced chronic arthritis models that
desensitization of the capsaicin-sensitive afferents results in increased disease severity
and inflammatory cell activity, coupled with diminished hyperalgesia [21–23]. However,
in prior studies the experimental layout way conceived based on the course of clinical
disease severity and functional changes. These results demonstrate that robust vascular
and cellular changes predate functional and morphological impairment, which should be
reflected by experimental protocols incorporation in in vivo imaging. Thus, imaging in the
clinically elusive, “black box” phase of the disease has a high potential to better understand
the underpinnings of functional and morphological arthritic changes.
It should be emphasized that the role of capsaicin-sensitive afferents is not ubiqui-
tously beneficial and depends on the pathophysiological mechanisms. We previously
showed that disease severity in e.g., the collagen antibody-induced RA model (CAIA) [24]
and inflammatory changes in the mast cell tryptase-induced acute arthritis model are
diminished after RTX-pretreatment [30]. This highlights the challenge posed by the various
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RA models, which typically only mimic certain aspects of the human disease maintained
by multiple autoantibodies and a complex underlying dysregulation of the immune system.
Furthermore, it also underlies that models dependent on a single aspect of the diseases
(e.g., mast cell activation, or a single autoantibody) do not necessarily address well the
role of the investigated pathway in a complex clinical condition. Nonetheless, all available
evidence indicates that in complex, multifactorial RA models, capsaicin-sensitive afferents
have predominantly anti-inflammatory effects.
The increased early-phase spontaneous photon emission is also interesting from
a technical standpoint, with several caveats. Our results show that even with sensitive
imaging sequences increased photon count is barely detectable with the current commercial
in vivo imaging systems. Administration of exogenous chemiluminescent sensors remains
necessary in order to reliably assess ROS production in living subjects. The observed
weak correlation between spontaneous photon emission and L-012 luminescence is in
good agreement with prior results [26]. It also suggests that the overlap between these
phenomena is partial, and spontaneous photon signal reflects different aspects of the
inflammatory free radical burst. It should be noted that L-012 is activated in the presence
of multiple free radicals released by both neutrophils and macrophages. Other luminescent
probes such as luminol and lucigenin have been shown to correlate more selectively with
neutrophil and macrophage activity respectively [31]. However, in order to detect ROS
burst at the earliest possible time point, in the current study we have utilized a broad
spectrum ROS sensor.
The protective role of capsaicin-sensitive afferents in the K/BxN serum transfer arthri-
tis model based on its profound effect on hyperacute vascular dysregulation and inflam-
matory cell activation is of great importance. Almost hundred years have passed since the
first clinical, anecdotal observations suggesting the role of neuro-immune crosstalk in RA.
Patients rendered hemiplegic by a prior stroke were observed to only develop arthritis on
the functioning, non-paralyzed side. This clinical experience was recently corroborated by
advanced in vivo imaging and transcriptomics methods, demonstrating that complete limb
denervation inhibits the early, joint-localized vascular hyperpermeability in the K/BxN
serum transfer model via modulating endothelial cell function [25]. However, denerva-
tion results in permanent injury to all motor, sympathetic, parasympathetic, and sensory
fibers, thereby blurring the intricate functions of these neural elements, not to mention the
consequent complete loss of limb function. In comparison, selective targeting of capsaicin-
sensitive afferents to facilitate their anti-inflammatory mediator production and release
without eliciting nociceptive signaling is technically feasible as a therapeutic approach as
previously shown preclinically e.g., by tonic, low frequency stimulation of these sensory
nerve terminals [32]. We have also shown previously that the absence of anti-inflammatory
mediators released by capsaicin-sensitive afferents, such as galanin results in increased
arthritis severity and vascular leakage in the K/BxN serum transfer model, while lack
of vasoactive mediators such as PACAP diminishes vascular hyperpermeability [9,10].
Further work is therefore warranted to characterize the key early phase local mediators
that are pivotal for the beneficial immune-regulatory effect of these afferents.
4. Materials and Methods
4.1. Animals
Twelve- to sixteen-week-old male BALB/c were used for the experiment. The animals
were bred at the SPF animal housing facility of the University of Pécs, and were subse-
quently kept at the Laboratory Animal House of the János Szentágothai Research Centre of
the University of Pécs at 24–25 ◦C and provided with standard rodent chow and water ad
libitum under 12h dark/12h light cycles.
The study was designed and conducted according to European legislation (Directive
2010/63/EU) and Hungarian Government regulation (40/2013., II. 14.) on the protection of
animals used for scientific purposes. The project was approved by the Animal Welfare Com-
mittee of the University of Pécs, and the National Scientific Ethical Committee on Animal
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Experimentation of Hungary and licensed by the Government Office of Baranya County
(license No. BA02/2000-28/2019, approved: 18 October 2019). All efforts were made to
keep the number of experimental animals involved in the study at the necessary minimum.
4.2. Resiniferatoxin (RTX)-Induced Sensory Desensitization
Long-lasting defunctionalization of capsaicin-sensitive afferents was achieved by sc.
treatment with high doses (10, 20, 70, and 100 µg/kg) of the ultrapotent capsaicin analogue
RTX (Sigma Aldrich, St. Louis, MO, USA) on four consecutive days [33]. Mice also received
simultaneously a solution containing 4% terbutaline-sulfate (AstraZeneca Ltd., Budapest,
Hungary), 4% theophylline-ethylene diamin (Gedeon Richter Plc., Budapest, Hungary),
and 2% athropine-sulfate (Egis Pharmaceuticals Plc., Budapest, Hungary) to decrease the
systemic, mainly respiratory side effects of the RTX treatment. RTX was previously proved
to be several magnitudes more potent TRPV1 receptor agonist than capsaicin, and it was
also demonstrated that loss of vanilloid receptor expression in the central nervous system
is not reversible [34,35]. After the desensitization has been completed the animals were left
undisturbed for a period of two weeks, to limit the confounding effect of resultant stress,
and also to allow for the systemic elimination of drugs used during the desensitization
process. Desensitization was verified by the lack of eye-wiping behavior following 10 µL,
0.1 % capsaicin drop [22]. The experiment was commenced shortly after verifying the
success of desensitization, in order to limit the potential biasing effects caused by peripheral
recovery of vanilloid receptor expression. Non-desensitized age-matched mice were given
the same treatment with the exception of RTX, and served as the control group. The
capsaicin drop test was not used in the latter group.
4.3. The K/BxN Serum Transfer Arthritis Model and the Experimental Layout
The sera of transgene positive (K/BxN) mice was obtained, pooled, and stored at
−80 ◦C as described previously [36–38]. Arthritis was induced by ip. injection of 300 µL
arthritogenic serum on day 0 of the experiment. In prior studies this was confirmed as a
dose capable of eliciting robust joint inflammation, with minimal intra-group variation of
disease severity [9].
Mice were monitored afterwards for 5 days with clinical scoring of arthritis severity,
fluorescence imaging of the vascular leakage, and luminescence imaging of free radical
production. Timing of fluorescent and luminescent imaging was different to reduce the
possibility of pharmacological interaction and volume overload, and also due to the
photosensitivity of the luminescent probe. On day 5 contrast-enhanced MRI of the ankle
joints was performed. Thereafter the experiment was terminated, and mice were humanely
euthanized by ip. sodium-pentobarbital.
4.4. Clinical Arthritis Severity Scoring
Arthritis severity was assessed daily by clinical semiquantitative scoring of joint
inflammatory changes (edema, hyperemia) on both hind limbs of the animals at 24 h
intervals based on the hyperemia, and swelling of the ankle, footpad, and digits respectively
(0–0.5 = intact limb, 10 = maximal swelling and hyperemia) throughout the experiment as
described previously in details [9,38,39].
4.5. Assessment of Plasma Extravasation and Vascular Permeability
Plasma extravasation was evaluated using the near-infrared fluorophore IR-676
(0.5 mg/kg, Spectrum-Info Ltd., Kyiv, Ukraine) dissolved in 5% (v/v) aqueous solution of Kol-
liphor HS 15 (polyethylene-glycol-15-hydroxystearate; Sigma-Aldrich, St. Louis, MO, USA),
yielding a micellar contrast agent accumulating in inflamed areas due to increased vascular
permeability [40]. The formula was injected intravenously (iv.) into anesthetized mice
through the retroorbital veins with a 0.5 mL insulin needle, the bevel oriented downwards
as described earlier [41] 5 h after the K/BxN serum transfer and on day 2. Short-term
anesthesia of multiple subjects has been done by administration of 120/6 mg/kg ketamine-
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xylazine ip. Fluorescence imaging of both ankle joints was performed in pairs 20 min
post-injection using the IVIS Lumina III (PerkinElmer, Waltham, MA, USA) in vivo imag-
ing system with the following settings: auto acquisition time, Binning = 2, F/stop = 2,
excitation/emission filter: 660/710 nm). Data were analyzed and regions of interests (ROI)
were drawn around the ankle joints. Fluorescence was expressed as total radiant efficiency
([photons/s/cm2/sr]/[µW/cm2]).
4.6. Evaluation of Free Radical Production
Free radical production by transmigrating neutrophils is an important early event in
inflammatory arthritis, and we have previously shown that it correlates well with other
(functional, histological) features of disease severity [9]. L-012 (Wako Pure Chemical
Industries Ltd., Osaka, Japan) is a luminol analog chemiluminescent probe that has been
shown to be very sensitive toward reactive oxygen and nitrogen species in vivo. L-012 was
dissolved in sterile physiologic saline, and was injected in a dose of 25 mg/kg i.p. under
as described previously [42] 3 h after K/BxN serum challenge, and on days 1 and 4 of the
experiment. Mice were imaged in ketamine/xylazine anesthesia 10 min after the injection
using the IVIS Lumina III system with the following settings: 120 s acquisition, Binning = 8,
F/Stop = 1). Identical ROIs were applied around the ankle joints and chemiluminescence
was expressed as total radiance (total photon flux/s).
4.7. Detection of In Vivo Spontaneous Ultraweak Photonic Emission
Prior to all further imaging anesthetized mice were imaged with the IVIS system using
a dedicated imaging setting, with the aim to detect spontaneously emitted, extremely weak
biophoton production resulting from singlet oxygen decay. For this purpose, a longer,
180 s luminescence acquisition was performed, with an increased binning factor of 16. To
exclude the bias effect of body heat changes the imaging chamber of the IVIS system was
maintained at 37 ◦C throughout the experiment.
4.8. In Vivo Contrast Enhanced MRI
In vivo contrast-enhanced MRI has been previously demonstrated to be suitable to
monitor and characterize joint damage in the K/BxN serum transfer model [43]. Imaging
was performed on day 5 of the experiment. Mice were anesthetized with 3% isoflurane, and
were transferred into the Bruker PharmaScan 4.7T (Bruker, Billerica, MA, USA) imaging
system. Because of the repeated acquisitions pre- and postcontrast adequate anesthesia
was maintained by further isoflurane inhalation through nosecone, while respiratory rate
was constantly monitored to control the depth of anesthesia. Mice were positioned on
their back, and the right ankle joint was then secured in a flexed position using a custom-
made styrofoam support and plastic strips. First a noncontrast 2D multislice T1 RARE
(TR: 1200 ms, TE: 8.3 ms) sequence had been performed in the saggital plane, then the
mice were briefly removed from the system, and while still under anesthesia 100 µL of
the gadolinium-based, clinically approved MRI contrast agent gadobutrol (Gadovist®,
Bayer Schering Pharma AG, Berlin, Germany) solution (1 mmol/mL) was injected i.v.
via the retro-orbital venous plexus. The mice were immediately transferred back to the
system afterwards, and the same sequence was repeated 10 min post-injection. Total
acquisition time of each sequence was approximately 45 min per animal. Images were
reconstructed using the Bruker ParaVision™ 6.0.1 software. The scans were exported in the
DICOM format, and ROI-based quantification was performed with the RadiAnt™ 2020.2
software [44]. In each scan ROIs have been applied to all tarsal and tibiotarsal joints clearly
depicted in the imaging plane, and the peak arbitrary signal value was used for further
assessment. Values from at least 3–5 joints/subject have been averaged, and this mean was
used for further comparison.
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4.9. Statistics
The clinical severity, fluorescent and luminescent optical imaging results were an-
alyzed using two-way ANOVA and the Fishers LSD test. Correlation between imaging
data and clinical severity was determined with linear regression and correlation. The
intra-articular enhancement on MRI was assessed with unpaired t-test. All analyses had
been performed in the GraphPad Prism™ 7.0 statistical software. All error bars represent
the standard errors of means (SEM), at least p < 0.05 was considered to be statistically
significant. Because of the small sample size no formal normality test was conducted.
5. Conclusions
The present results provide the first evidence for pivotal protective roles of capsaicin-
sensitive afferents in the hyperacute phase of inflammatory arthritis. Their activity reduces
vascular leakage. This is also coupled with diminished leukocyte ROS burst, which can
be an indirect outcome of the vascular changes and consequently decreased ability to
transmigrate into the inflamed joint tissues, and/or also due to direct inhibitory action
via local mediators. The above parameters show correlation with each other and the
disease severity observed later on. Furthermore, optical imaging methods provide sen-
sitive, specific, and reliable tools to investigate the mechanisms related to the very early
inflammatory phase, which is not possible with conventional functional and morphological
investigational techniques.
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